Salma Khan

1.9k total citations · 1 hit paper
38 papers, 1.5k citations indexed

About

Salma Khan is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Salma Khan has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in Salma Khan's work include Extracellular vesicles in disease (12 papers), RNA Interference and Gene Delivery (6 papers) and MicroRNA in disease regulation (6 papers). Salma Khan is often cited by papers focused on Extracellular vesicles in disease (12 papers), RNA Interference and Gene Delivery (6 papers) and MicroRNA in disease regulation (6 papers). Salma Khan collaborates with scholars based in United States, Norway and Canada. Salma Khan's co-authors include Nathan R. Wall, Jonathan R. Aspe, Jessica M.S. Jutzy, Saied Mirshahidi, David Turay, Jonathan W. Neidigh, Malyn May Asuncion Valenzuela, Michelle M. Lilly, Yuan Yuan and Dan Mercola and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Salma Khan

36 papers receiving 1.5k citations

Hit Papers

Advances in CAR T cell therapy: antigen selection, modifi... 2025 2026 2025 5 10 15 20
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
    2025 20 citations Salma Khan, Yeonjoo Choi et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salma Khan United States 18 1.2k 599 225 218 135 38 1.5k
Saied Mirshahidi United States 21 906 0.8× 463 0.8× 370 1.6× 300 1.4× 157 1.2× 66 1.5k
Pamela Della Mina Italy 12 1.0k 0.8× 635 1.1× 249 1.1× 181 0.8× 82 0.6× 15 1.4k
Harvey W. Smith Canada 13 836 0.7× 450 0.8× 215 1.0× 304 1.4× 131 1.0× 18 1.4k
Kosuke Mizutani Japan 20 834 0.7× 474 0.8× 218 1.0× 336 1.5× 310 2.3× 83 1.5k
Ursula E. Lang United States 13 1.3k 1.1× 471 0.8× 557 2.5× 549 2.5× 151 1.1× 31 1.8k
Julia V. Burnier Canada 21 592 0.5× 318 0.5× 174 0.8× 408 1.9× 123 0.9× 73 1.2k
Justin Sturge United Kingdom 21 745 0.6× 316 0.5× 156 0.7× 360 1.7× 180 1.3× 31 1.4k
Pedram Kharaziha Sweden 14 795 0.7× 427 0.7× 127 0.6× 201 0.9× 104 0.8× 25 1.4k
Jérôme Paggetti Luxembourg 18 1.2k 1.0× 694 1.2× 691 3.1× 399 1.8× 81 0.6× 38 1.9k
Taewon Yoon United States 7 1.2k 1.0× 709 1.2× 470 2.1× 512 2.3× 128 0.9× 7 1.7k

Countries citing papers authored by Salma Khan

Since Specialization
Citations

This map shows the geographic impact of Salma Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salma Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salma Khan more than expected).

Fields of papers citing papers by Salma Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salma Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salma Khan. The network helps show where Salma Khan may publish in the future.

Co-authorship network of co-authors of Salma Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Salma Khan. A scholar is included among the top collaborators of Salma Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salma Khan. Salma Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Salma, Yeonjoo Choi, Mysore S. Veena, John K. Lee, & Daniel Sanghoon Shin. (2025). Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors. Frontiers in Immunology. 15. 1489827–1489827. 20 indexed citations breakdown →
2.
Kim, Hae Soo, Andrea Shields, Saied Mirshahidi, et al.. (2023). Regulatory and Interacting Partners of PDLIM7 in Thyroid Cancer. Current Oncology. 30(12). 10450–10462. 1 indexed citations
3.
4.
5.
Wang, Hanmin, Ryan M. Davis, Alfred Simental, et al.. (2021). Differential Expression of Non-Coding RNA Signatures in Thyroid Cancer between Two Ethnic Groups. Current Oncology. 28(5). 3610–3628. 4 indexed citations
6.
Khan, Salma, et al.. (2020). Differential MicroRNA-Signatures in Thyroid Cancer Subtypes. Journal of Oncology. 2020. 1–14. 53 indexed citations
7.
Khan, Salma, Jennifer S. Simpson, James C. Lynch, et al.. (2017). Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. PLoS ONE. 12(10). e0183122–e0183122. 22 indexed citations
8.
Gonda, Amber, et al.. (2017). Uptake of lymphoma-derived exosomes by peripheral blood leukocytes. PubMed. Volume 7. 9–23. 12 indexed citations
9.
Turay, David, Salma Khan, Carlos J. Díaz Osterman, et al.. (2015). Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients. Cancer Investigation. 34(1). 1–11. 58 indexed citations
10.
Wall, Nathan R., Amber Gonda, Jessica M.S. Jutzy, et al.. (2015). Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase. OncoTargets and Therapy. 8. 495–495. 9 indexed citations
11.
Khan, Salma, et al.. (2014). Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer. 14(1). 176–176. 178 indexed citations
12.
Bam, Rakesh, Sathisha Upparahalli Venkateshaiah, Salma Khan, et al.. (2014). Role of Bruton’s tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells. Blood Cancer Journal. 4(8). e234–e234. 9 indexed citations
13.
Jutzy, Jessica M.S., et al.. (2012). Tumor-Released Survivin Induces a Type-2 T Cell Response and Decreases Cytotoxic T Cell Function, in Vitro. Cancer Microenvironment. 6(1). 57–68. 15 indexed citations
14.
Khan, Salma, et al.. (2010). Survivin is released from cancer cells via exosomes. APOPTOSIS. 16(1). 1–12. 222 indexed citations
15.
Khan, Salma, Jonathan R. Aspe, Frankis Almaguel, et al.. (2009). Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. British Journal of Cancer. 100(7). 1073–1086. 129 indexed citations
16.
Pisarska, Margareta D., et al.. (2008). Expression of forkhead transcription factors in human granulosa cells. Fertility and Sterility. 91(4). 1392–1394. 28 indexed citations
17.
Khan, Salma, et al.. (2004). PTEN promoter is methylated in a proportion of invasive breast cancers. International Journal of Cancer. 112(3). 407–410. 101 indexed citations
18.
Khan, Salma, et al.. (2004). Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma. British Journal of Haematology. 125(2). 156–161. 84 indexed citations
19.
Khan, Salma, H. Katabuchi, Takeshi Ohba, et al.. (2000). The Molar Vesicle Fluid Contains the β-Core Fragment of Human Chorionic Gonadotropin. Placenta. 21(1). 79–87. 8 indexed citations
20.
Russell, Charles D., et al.. (1995). Techniques for measuring renal transit time. European Journal of Nuclear Medicine and Molecular Imaging. 22(12). 1372–1378. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saied Mirshahidi Breakdown of academic impact, for papers by Pamela Della Mina Breakdown of academic impact, for papers by Harvey W. Smith Breakdown of academic impact, for papers by Kosuke Mizutani Breakdown of academic impact, for papers by Ursula E. Lang Breakdown of academic impact, for papers by Julia V. Burnier Breakdown of academic impact, for papers by Justin Sturge Breakdown of academic impact, for papers by Pedram Kharaziha Breakdown of academic impact, for papers by Jérôme Paggetti Breakdown of academic impact, for papers by Taewon Yoon
Rankless by CCL
2026